Etanercept treatment of cutaneous granulomas in common variable immunodeficiency

The Journal of Allergy and Clinical Immunology
Joann H LinE Richard Stiehm

Abstract

Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by hypogammaglobulinemia, poor antibody responses, and recurrent bacterial infections, usually of the sinorespiratory tract. A not uncommon complication is granuloma of the lungs, spleen, liver, and/or skin. We report the case of an 18-year-old boy with CVID and chronic granulomas of the left arm (since 13 years of age) refractory to treatment with antibiotics, intravenous immunoglobulin, antifungal agents, systemic and intralesional steroids, IFN-gamma, cyclosporine, methotrexate, hydroxychloroquine, localized radiation therapy, and surgical excision. The lesions improved after treatment with the systemic administration of the TNF-alpha inhibitor etanercept for 1 year. Etanercept prevents soluble TNF from binding to its cell membrane receptor, leading to inhibition of its inflammatory cascade. We recommend further trials of etanercept in patients with CVID with noninfectious recalcitrant granulomas.

Citations

Sep 19, 2012·Journal of Clinical Immunology·Jean-Nicolas BoursiquotUNKNOWN DEFI study group
Jan 18, 2007·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Paula J BusseCharlotte Cunningham-Rundles
Jun 5, 2007·Pediatric Dermatology·Antonio TorreloAntonio Zambrano
Nov 21, 2007·Annals of the Rheumatic Diseases·D E FurstM E Weinblatt
Apr 23, 2008·Journal of Medical Case Reports·Umesh C Yalavarthy, Mukta Panda
Apr 13, 2010·Italian Journal of Pediatrics·Laura FolgoriAndrea Finocchi
Jul 27, 2014·Journal of Clinical Immunology·Timothy J FranxmanJames R Baker
Oct 18, 2013·The Journal of Allergy and Clinical Immunology·Paul J MaglioneCharlotte Cunningham-Rundles
Dec 7, 2013·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Mark Ballow
Nov 14, 2015·The Journal of Allergy and Clinical Immunology. in Practice·Francisco A BonillaKlaus Warnatz
Aug 16, 2011·Journal of the American Academy of Dermatology·Angana MitraJulia A Newton-Bishop
Jul 1, 2011·The Journal of Allergy and Clinical Immunology·Despina MoshousAlain Fischer
Feb 1, 2011·Annales de dermatologie et de vénéréologie·J BoudartJ André
Sep 1, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Omür Ardeniz, Charlotte Cunningham-Rundles
Dec 19, 2006·Allergologia et immunopathologia·A Blanco-QuirósE Arranz-Sanz
Oct 12, 2015·Immunology and Allergy Clinics of North America·Jordan K Abbott, Erwin W Gelfand
Apr 7, 2009·British Journal of Haematology·Helen Chapel, Charlotte Cunningham-Rundles
Oct 11, 2012·Head & Neck·Robert H LindauRussell B Smith
Dec 19, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Alejandro MalbránDiego S Fernández Romero
Apr 23, 2014·British Journal of Clinical Pharmacology·Eve Md SmithMichael W Beresford
Mar 17, 2015·International Journal of Dermatology·Joanna HarpTimothy G Berger
Jan 22, 2008·Primary Care·Yoshikazu Morimoto, John M Routes
Mar 25, 2010·Blood·Charlotte Cunningham-Rundles
Jun 26, 2007·The Journal of Allergy and Clinical Immunology·Javier Chinen, William T Shearer
May 19, 2010·Expert Review of Clinical Immunology·Drahomíra Detková, Teresa Español
Jul 26, 2014·The American Journal of Dermatopathology·Arti NandaHejab Al-Ajmi
Jun 5, 2013·Expert Review of Clinical Immunology·Hassan AbolhassaniAsghar Aghamohammadi
Oct 4, 2018·Frontiers in Immunology·Sandra WoelkeStefan Zielen
Dec 20, 2018·Immunological Reviews·Charlotte Cunningham-Rundles
Jan 1, 2009·Clinical Medicine. Case Reports·Branka FilipovićGoran Nikolić
Jun 1, 2016·The Clinical Respiratory Journal·Basheer TashtoushJinesh Mehta
Jan 5, 2021·Frontiers in Immunology·Astrid C van StigtHanna IJspeert
Jan 15, 2019·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Heather MintoErwin W Gelfand

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Cat-scratch disease

Cat-scratch disease, a relatively common infectious disease, is caused by Bartonella henselae and characterized by a fever and regional lymphadenitis. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved